- Home
- MRNA vs HTHT Comparison
MRNA vs HTHT Comparison
Compare MRNA & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- HTHT
- Stock Information
- Founded
- MRNA 2010
- HTHT 2005
- Country
- MRNA United States
- HTHT China
- Employees
- MRNA N/A
- HTHT N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- HTHT Hotels/Resorts
- Sector
- MRNA Health Care
- HTHT Consumer Discretionary
- Exchange
- MRNA Nasdaq
- HTHT Nasdaq
- Market Cap
- MRNA 9.8B
- HTHT 11.4B
- IPO Year
- MRNA 2018
- HTHT 2010
- Fundamental
- Price
- MRNA $27.16
- HTHT $38.60
- Analyst Decision
- MRNA Hold
- HTHT Strong Buy
- Analyst Count
- MRNA 15
- HTHT 2
- Target Price
- MRNA $37.15
- HTHT $45.00
- AVG Volume (30 Days)
- MRNA 10.8M
- HTHT 1.2M
- Earning Date
- MRNA 11-06-2025
- HTHT 11-25-2025
- Dividend Yield
- MRNA N/A
- HTHT 5.01%
- EPS Growth
- MRNA N/A
- HTHT 0.96
- EPS
- MRNA N/A
- HTHT 1.66
- Revenue
- MRNA $3,078,000,000.00
- HTHT $3,390,100,226.00
- Revenue This Year
- MRNA N/A
- HTHT $5.90
- Revenue Next Year
- MRNA $11.12
- HTHT $6.34
- P/E Ratio
- MRNA N/A
- HTHT $23.22
- Revenue Growth
- MRNA N/A
- HTHT 4.24
- 52 Week Low
- MRNA $23.15
- HTHT $30.13
- 52 Week High
- MRNA $56.70
- HTHT $40.56
- Technical
- Relative Strength Index (RSI)
- MRNA 52.43
- HTHT 56.65
- Support Level
- MRNA $24.25
- HTHT $37.60
- Resistance Level
- MRNA $29.20
- HTHT $39.10
- Average True Range (ATR)
- MRNA 1.44
- HTHT 0.74
- MACD
- MRNA -0.03
- HTHT -0.00
- Stochastic Oscillator
- MRNA 58.79
- HTHT 71.33
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About HTHT H World Group Limited
H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, managed, and franchised models. The company has two operating segments: legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.